Role of Ayurveda herbomineral tablet to improve the quality of life of children with Autism

A Randomized Controlled clinical study On AUROKID PLUS tablet as adjuvant therapy in the management of Autism Spectrum Disorders in Children

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066055

Enrollment

Registered

2024-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F948- Other childhood disorders of social functioning

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with known cases of ASD children belonging to the age group of 3 to 12 years Parents or Guardian willing to give informed written consent to participate in the study Only Pre-diagnosed cases will be taken

Exclusion criteria

Exclusion criteria: Children under 5 years and above 16 years of age Presence of any neurological disorder Patient with known case of acute and chronic systemic disease like renal diseases Hepatic dysfunction Malignancy Cardiovascular Respiratory diseases

Design outcomes

Primary

Measure	Time frame
Improvement in ISAA (Indian Scale for Assessment of Autism) scoreTimepoint: 30 and 60 Day	—

Secondary

Measure	Time frame
Improvement in Quality of Life on the basis of WHO QoL questionerTimepoint: 30 and 60 day	—

Countries

India

Contacts

Public ContactDr Swapnil C Rasakar

Parul Institute of Ayurved

neonatecare99@gmail.com9726587013

Outcome results